Skip to content Skip to navigation

20 / 20 Blog Archive

Feb 21 2018 | MD Magazine | Posted In: 20/20 Blog, Press
Understanding the distinct features of the fovea, macula, and periphery is crucial in the development of effective targeted treatment therapies for various conditions, including age-related macular degeneration (AMD), cystoid macular edema, retinitis pigmentosa, and diabetic retinopathy.
Dec 21 2017 | Stanford Report | Posted In: 20/20 Blog, Press
Researchers are studying proteins in the eye to find existing drugs that can treat a rare eye disease known as neovascular inflammatory vitreoretinopathy that causes blindness.   Demonstrating the potential of precision health, a team led by a researcher at the Stanford University School of...
Dec 13 2017 | Posted In: 20/20 Blog
Using proteomics to identify new drug targets for PVR.
Nov 23 2017 | Posted In: 20/20 Blog
Adeno-associated viral (AAV) gene therapy restores axial eye length in a mouse model for nanophthalmos.
Apr 5 2017 | Posted In: 20/20 Blog
LC-MS/MS analysis of aqueous humor in a patient with suspected Schwartz Syndrome.

Pages